Home > National Drug Code (NDC) > Ganirelix Acetate

Ganirelix Acetate - 0052-0301-51 - (Ganirelix Acetate)

Alphabetical Index


Drug Information of Ganirelix Acetate

Product NDC: 0052-0301
Proprietary Name: Ganirelix Acetate
Non Proprietary Name: Ganirelix Acetate
Active Ingredient(s): 250    ug/.5mL & nbsp;   Ganirelix Acetate
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Ganirelix Acetate

Product NDC: 0052-0301
Labeler Name: Organon Pharmaceuticals USA
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021057
Marketing Category: NDA
Start Marketing Date: 19990729

Package Information of Ganirelix Acetate

Package NDC: 0052-0301-51
Package Description: 1 BLISTER PACK in 1 CARTON (0052-0301-51) > 1 SYRINGE, GLASS in 1 BLISTER PACK > 1 mL in 1 SYRINGE, GLASS

NDC Information of Ganirelix Acetate

NDC Code 0052-0301-51
Proprietary Name Ganirelix Acetate
Package Description 1 BLISTER PACK in 1 CARTON (0052-0301-51) > 1 SYRINGE, GLASS in 1 BLISTER PACK > 1 mL in 1 SYRINGE, GLASS
Product NDC 0052-0301
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Ganirelix Acetate
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 19990729
Marketing Category Name NDA
Labeler Name Organon Pharmaceuticals USA
Substance Name GANIRELIX ACETATE
Strength Number 250
Strength Unit ug/.5mL
Pharmaceutical Classes Decreased GnRH Secretion [PE],Gonadotropin Releasing Hormone Antagonist [EPC],Gonadotropin Releasing Hormone Receptor Antagonists [MoA]

Complete Information of Ganirelix Acetate


General Information